Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, and the mortality rate from COPD has been increasing over the past two decades. Cigarette smoking is the most important risk factor, but the development of airflow obstruction among smokers is variable. Family studies have suggested a genetic contribution to the development of COPD, but severe alpha 1-antitrypsin deficiency has been the only proven genetic risk factor to date. Previous studies have demonstrated evidence for linkage of COPD to a region on chromosome 19q. We hypothesize that one or more genes that are located on chromosome 19q influence susceptibility to COPD, especially in cigarette smokers, and that these genes can be identified using a high-resolution single nucleotide polymorphism (SNP) mapping strategy. To test this hypothesis, we propose to genotype approximately 1500 SNPs across the linked region in two case control populations. In separate genetic association analyses, cases from the Boston Early-Onset COPD Study will be compared to controls from the Nurses Health Study, and cases from the National Emphysema Treatment Trial will be compared to controls from the Normative Aging Study. Positive associations will be validated in the extended pedigrees from the Boston Early-Onset COPD Study. The use of high-density SNP mapping with association analysis in two case-control samples and validation in a family-based study design should permit the identification of a COPD-susceptibility locus on chromosome 19q, which could result in better understanding of COPD pathogenesis and could highlight pathways and targets for new COPD therapies. The proposed project will train the principal investigator to become an independent investigator in the field of genetic epidemiology of airways disease, through a series of courses, seminars, and supervised research in the areas of genetic epidemiology, molecular genetics, and bioinformatics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL080242-02
Application #
7096608
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F2))
Program Officer
Rothgeb, Ann E
Project Start
2005-07-14
Project End
2010-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$133,633
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Hardin, Megan; Silverman, Edwin K; Barr, R Graham et al. (2011) The clinical features of the overlap between COPD and asthma. Respir Res 12:127
Kim, Deog Kyeom; Jacobson, Francine L; Washko, George R et al. (2011) Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med 105:1211-21
Hersh, Craig P; Hokanson, John E; Lynch, David A et al. (2011) Family history is a risk factor for COPD. Chest 140:343-350
Qiu, Weiliang; Cho, Michael H; Riley, John H et al. (2011) Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One 6:e24395
Hersh, Craig P; Silverman, Edwin K; Gascon, Jody et al. (2011) SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. Am J Respir Crit Care Med 183:1482-9
Kim, Deog Kyeom; Hersh, Craig P; Washko, George R et al. (2011) Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res 12:9
Sørheim, Inga-Cecilie; Bakke, Per; Gulsvik, Amund et al. (2010) ??-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 138:1125-32
Hersh, Craig P (2010) Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics 11:237-47
Hersh, Craig P; Pillai, Sreekumar G; Zhu, Guohua et al. (2010) Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med 182:605-13
Sørheim, I C; DeMeo, D L; Washko, G et al. (2010) Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD 7:262-8

Showing the most recent 10 out of 24 publications